Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway

Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway

Metabolic regulation of cancer cell growth via AMP-activated protein kinase (AMPK) activation is a widely studied strategy for cancer treatment, including leukemias. Recent notions that naturally occurring compounds might have AMPK activity led to the search for nutraceuticals with potential AMPK-st...

Full description

Bibliographic Details
Main Authors: Doriana Verrelli, Luca Dallera, Massimo Stendardo, Silvia Monzani, Sebastiano Pasqualato, Marco Giorgio, Rani Pallavi
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Nutrients
Subjects:
nutraceuticals
hydroxycitric acid
AMPK
CML
Online Access:https://www.mdpi.com/2072-6643/14/13/2669

Internet

https://www.mdpi.com/2072-6643/14/13/2669

Similar Items